Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial.
Dantal J, Berthoux F, Moal MC, Rostaing L, Legendre C, Genin R, Toupance O, Moulin B, Merville P, Rerolle JP, Bayle F, Westeel PF, Glotz D, Kossari N, Lefrançois N, Charpentier B, Quéré S, Di Giambattista F, Cassuto E; RAD A2420 Study Group. Dantal J, et al. Among authors: charpentier b. Transpl Int. 2010 Nov;23(11):1084-93. doi: 10.1111/j.1432-2277.2010.01094.x. Epub 2010 Aug 19. Transpl Int. 2010. PMID: 20500493 Free article. Clinical Trial.
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients.
Charpentier B, Rostaing L, Berthoux F, Lang P, Civati G, Touraine JL, Squifflet JP, Vialtel P, Abramowicz D, Mourad G, Wolf P, Cassuto E, Moulin B, Rifle G, Pruna A, Merville P, Mignon F, Legendre C, Le Pogamp P, Lebranchu Y, Toupance O, Hurault De Ligny B, Touchard G, Olmer M, Purgus R, Pouteil-Noble C, Glotz D, Bourbigot B, Leski M, Wauters JP, Kessler M. Charpentier B, et al. Transplantation. 2003 Mar 27;75(6):844-51. doi: 10.1097/01.TP.0000056635.59888.EF. Transplantation. 2003. PMID: 12660513 Clinical Trial.
Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric-coated mycophenolate sodium and steroids: results of follow up to 30 months post-transplant.
Mourad G, Karras A, Kamar N, Garrigue V, Legendre C, Lefrançois N, Charpentier B, Bourbigot B, Pouteil-Noble C, Bayle F, Lebranchu Y, Mariat C, Le Meur Y, Kessler M, Moulin B, Ducloux D, Delahousse M, Lang P, Merville P, Chaouche-Teyara K, Rostaing L; French Myriade FR01 Study Group. Mourad G, et al. Among authors: charpentier b. Clin Transplant. 2007 May-Jun;21(3):295-300. doi: 10.1111/j.1399-0012.2007.00660.x. Clin Transplant. 2007. PMID: 17488375 Clinical Trial.
Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
Albano L, Berthoux F, Moal MC, Rostaing L, Legendre C, Genin R, Toupance O, Moulin B, Merville P, Rerolle JP, Bayle F, Westeel PF, Glotz D, Kossari N, Lefrançois N, Charpentier B, Blanc AS, Di Giambattista F, Dantal J; RAD A2420 Study Group. Albano L, et al. Among authors: charpentier b. Transplantation. 2009 Jul 15;88(1):69-76. doi: 10.1097/TP.0b013e3181aa7d87. Transplantation. 2009. PMID: 19584683 Clinical Trial.
Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids.
Glotz D, Charpentier B, Abramovicz D, Lang P, Rostaing L, Rifle G, Vanrenterghem Y, Berthoux F, Bourbigot B, Delahousse M, Chalopin JM, Cassuto E, Lefrançois N. Glotz D, et al. Among authors: charpentier b. Transplantation. 2010 Jun 27;89(12):1511-7. doi: 10.1097/TP.0b013e3181db09e4. Transplantation. 2010. PMID: 20386144 Clinical Trial.
Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The 'reference' study.
Frimat L, Cassuto-Viguier E, Charpentier B, Noël C, Provôt F, Rostaing L, Glotz D, Sraer JD, Bourbigot B, Moulin B, Lang P, Ducloux D, Pouteil-Noble C, Girardot-Seguin S, Kessler M. Frimat L, et al. Among authors: charpentier b. Am J Transplant. 2006 Nov;6(11):2725-34. doi: 10.1111/j.1600-6143.2006.01535.x. Am J Transplant. 2006. PMID: 17049060 Free article. Clinical Trial.
Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients.
Noël C, Abramowicz D, Durand D, Mourad G, Lang P, Kessler M, Charpentier B, Touchard G, Berthoux F, Merville P, Ouali N, Squifflet JP, Bayle F, Wissing KM, Hazzan M. Noël C, et al. Among authors: charpentier b. J Am Soc Nephrol. 2009 Jun;20(6):1385-92. doi: 10.1681/ASN.2008101037. Epub 2009 May 21. J Am Soc Nephrol. 2009. PMID: 19470677 Free PMC article. Clinical Trial.
ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus.
Rummo OO, Carmellini M, Rostaing L, Oberbauer R, Christiaans MH, Mousson C, Langer RM, Citterio F, Charpentier B, Brown M, Kazeem G, Lehner F; ADHERE study investigators. Rummo OO, et al. Among authors: charpentier b. Transpl Int. 2017 Jan;30(1):83-95. doi: 10.1111/tri.12878. Epub 2016 Nov 28. Transpl Int. 2017. PMID: 27754567 Free article. Clinical Trial.
An open multicenter trial of conversion from Sandimmun to Neoral in stable kidney-transplant patients.
Hourmant M, Antoine C, Bayle F, Bedrossian J, Berthoux F, Cassuto E, Chalopin JM, Charpentier B, Deteix P, Durand D, Hurault de Ligny B, Kessler M, Kreis H, Lang P, Lebranchu Y, Leroux-Robert C, Moulin B, Mourad G, Noël C, Olmer M, Potaux L, Pouteil-Noble C, Pruna A, Sraër JD, Soulillou JP, et al. Hourmant M, et al. Among authors: charpentier b. Transplant Proc. 1997 Aug;29(5):2313-4. doi: 10.1016/s0041-1345(97)00381-3. Transplant Proc. 1997. PMID: 9270741 Clinical Trial. No abstract available.
467 results